To confirm whether the activation of Akt pathway can be blocked to reverse the NET1-induced HCC phenotype, MK2206, a potent Akt inhibitor, was incubated with NET1-overexpressed Hep3B and Huh7 cells. This evidence concerns the gene AKT1 and hepatocellular carcinoma.